1,869
Views
4
CrossRef citations to date
0
Altmetric
Rotavirus – Research Paper

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study

ORCID Icon, , ORCID Icon &
Article: 2040329 | Received 22 Sep 2021, Accepted 06 Feb 2022, Published online: 03 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Prashant Kumar, Christopher Bird, David Holland, Sangeeta B. Joshi & David B. Volkin. (2022) Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication. Human Vaccines & Immunotherapeutics 18:7.
Read now

Articles from other publishers (3)

Sarwat Mahmud, Ranju Baral, Colin Sanderson, Clint Pecenka, Mark Jit, You Li & Andrew Clark. (2023) Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries. BMC Medicine 21:1.
Crossref
Aileen Murphy, Ann Kirby & Federica De Blasio. (2023) The economic impact of the introduction of universal rotavirus vaccination on rotavirus gastroenteritis related hospitalisations in children in Ireland. Vaccine 41:16, pages 2656-2663.
Crossref
Jessie Chen, Stephanie Grow, Miren Iturriza-Gómara, William P. Hausdorff, Alan Fix & Carl D. Kirkwood. (2022) The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers. Viruses 14:11, pages 2565.
Crossref